Brand owners working with contract manufacturers must prioritize supply chain transparency in order to meet all the regulatory obligations. This includes brand owners knowing specifications for their product testing, stability and ingredients. Also a contact...
Non-Compliance is the biggest threat to growth of the Pharmaceutical and Nutraceutical industry today. The number of warning letters issued by the Food & Drug Administration (FDA) has increased drastically since 2016. The cost of a single non-compliance event is...
The FDA has issued warning letters on SARMs in dietary supplements. FDA has cautioned products containing Selective Androgen Receptor Modulators (SARMs) are unapproved drugs the agency has not reviewed for safety and effectiveness. Recent warning letters show FDA is...
Products classified as drugs require to disclose all potential side effects to consumers and must get FDA approval before going to the market. Here we briefly go through drugs vs cosmetics. These products are also required to prove their safety and effectiveness. Any...
The Food and Drug Administration (FDA) is using all available tools at its disposal to crack down on dietary supplements containing a stimulant called dimethylamylamine (DMAA) are no longer distributed and available for sale to consumers. These actions are being taken...
